# Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.

> **NCT02978508** · PHASE3 · COMPLETED · sponsor: **Mayne Pharma International Pty Ltd** · enrollment: 140 (actual)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** Permethrin Cream, 5%
- **DRUG:** Elimite

## Key facts

- **NCT ID:** NCT02978508
- **Lead sponsor:** Mayne Pharma International Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02978508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02978508, "Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02978508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*